These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1741654)

  • 1. Chronic ACE inhibition reduces intimal hyperplasia in experimental vein grafts.
    O'Donohoe MK; Schwartz LB; Radic ZS; Mikat EM; McCann RL; Hagen PO
    Ann Surg; 1991 Dec; 214(6):727-32. PubMed ID: 1741654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased concentrations of angiotensin-converting enzyme in the intimal hyperplasia of experimental vein grafts.
    O'Donohoe MK; Davies MG; Radic ZS; Mikat EM; Hagen PO
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):594-601. PubMed ID: 7516009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment.
    el-Sanadiki MN; Cross KS; Murray JJ; Schuman RW; Mikat E; McCann RL; Hagen PO
    Ann Surg; 1990 Jul; 212(1):87-96. PubMed ID: 2363608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
    Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809.
    Fulton GJ; Davies MG; Barber L; Svendsen E; Hagen PO
    Surgery; 1998 Feb; 123(2):218-27. PubMed ID: 9481409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic hypertension alters vasomotor function in experimental vein grafts.
    O'Donohoe MK; Radic ZS; Schwartz LB; Mikat EM; McCann RL; Hagen PO
    J Vasc Surg; 1991 Jul; 14(1):30-9. PubMed ID: 2061958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of experimental vein graft intimal hyperplasia by ketanserin.
    Massey MF; Davies MG; Svendsen E; Klyachkin ML; Schwartz LB; Barber L; McCann RL; Hagen PO
    J Surg Res; 1993 Jun; 54(6):530-8. PubMed ID: 8412062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of angiotensin II receptor mediated responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809.
    Davies MG; Fulton GJ; Barber L; Dalen H; Svendsen E; Hagen PO
    Eur J Vasc Endovasc Surg; 1996 Aug; 12(2):151-61. PubMed ID: 8760976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative reduction of high serum cholesterol concentrations and experimental vein bypass grafts. Effect on the development of intimal hyperplasia and abnormal vasomotor function.
    Klyachkin ML; Davies MG; Kim JH; Barber L; Dalen H; Svendsen E; Hagen PO
    J Thorac Cardiovasc Surg; 1994 Sep; 108(3):556-66. PubMed ID: 8078349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercholesterolemia and experimental vein grafts: accelerated development of intimal hyperplasia and an increase in abnormal vasomotor function.
    Klyachkin ML; Davies MG; Svendsen E; Kim JH; Massey MF; Barber L; McCann RL; Hagen PO
    J Surg Res; 1993 May; 54(5):451-68. PubMed ID: 8361171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
    Fulton GJ; Barber L; Svendsen E; Hagen PO; Davies MG
    J Surg Res; 1997 Apr; 69(1):128-34. PubMed ID: 9202658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta1 expression and the role of angiotensin-converting enzyme inhibitor on perianastomotic intimal hyperplasia in polytetrafluoroethylene graft implanted in rabbit carotid artery.
    Um JW; Kim JM; Min BW; Kim YS; Son GS; Lee JB; Jung SI; Kim SJ; Choi SY; Koo BH; Ishibashi N; Shirouzu K; Whang CW
    Kurume Med J; 2004; 51(3-4):235-43. PubMed ID: 15682830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness of vein bypass grafts to stimulation with norepinephrine and 5-hydroxytryptamine.
    Makhoul RG; Davis WS; Mikat EM; McCann RL; Hagen PO
    J Vasc Surg; 1987 Jul; 6(1):32-8. PubMed ID: 3599278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of lipid peroxidation with intraoperative superoxide dismutase treatment decreases intimal hyperplasia in experimental vein grafts.
    Huynh TT; Davies MG; Trovato MJ; Barber L; Safi HJ; Hagen PO
    J Surg Res; 1999 Jun; 84(2):223-32. PubMed ID: 10357924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts.
    Fulton GJ; Davies MG; Barber L; Gray JL; Svendsen E; Hagen PO
    Eur J Vasc Endovasc Surg; 1998 Apr; 15(4):279-89. PubMed ID: 9610339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of accelerated vein graft atheroma with the nitric oxide precursor: L-arginine.
    Davies MG; Dalen H; Kim JH; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1995 Jul; 59(1):35-42. PubMed ID: 7630134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts.
    Fulton GJ; Davies MG; Koch WJ; Dalen H; Svendsen E; Hagen PO
    J Vasc Surg; 1997 Mar; 25(3):453-63. PubMed ID: 9081126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen Sulphide Release via the Angiotensin Converting Enzyme Inhibitor Zofenopril Prevents Intimal Hyperplasia in Human Vein Segments and in a Mouse Model of Carotid Artery Stenosis.
    Macabrey D; Deslarzes-Dubuis C; Longchamp A; Lambelet M; Ozaki CK; Corpataux JM; Allagnat F; Déglise S
    Eur J Vasc Endovasc Surg; 2022 Feb; 63(2):336-346. PubMed ID: 34916111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ramipril and experimental vein graft intimal hyperplasia.
    Davies MG; Klyachkin ML; Barber L; Svendsen E; Hagen PO
    Angiology; 1995 Feb; 46(2):91-7. PubMed ID: 7702205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of vein graft intimal hyperplasia and preservation of endothelium-dependent relaxation by topical vascular endothelial growth factor.
    Luo Z; Asahara T; Tsurumi Y; Isner JM; Symes JF
    J Vasc Surg; 1998 Jan; 27(1):167-73. PubMed ID: 9474095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.